WORLD PSORIASIS DAY - 29TH OCTOBER 2020
World Psoriasis Day 2020: Often misdiagnosed and untreated, skin disease can cause inflammation in internal organs Psoriasis primarily affects the skin, but can also cause inflammation in the internal organs, especially in the cardiovascular system, and lead to the metabolic syndrome, which includes a range of associated diseases Psoriasis is a skin disease, a chronic disease and an autoimmune disease. Given how complex this disease is and the fact that it has a high prevalence and tends to go undiagnosed or misdiagnosed to a large extent, awareness about it is vital. World Psoriasis Day, observed on 29 October, is when awareness campaigns are amplified globally to fight this disease. Keeping up with this target, the theme of World Psoriasis Day 2020 is “Informed”. Dr Monica Bambroo, Head of Dermatology and Cosmetology, Artemis Hospitals, Gurugram, shed light on why this disease needs more spotlight than it gets, especially within the Indian healthcare system. Not just skin deep Characterised by scaly patches on the skin that grow and shed very fast, psoriasis is not just any skin disease. “The common man assumes that skin diseases are either fungal or bacterial in nature but that’s not the case with psoriasis,” says Dr Bambroo. “Psoriasis is a systemic disease, which is why it’s classified as an autoimmune disease. Your immune system is supposed to protect you, keep you safe. But sometimes, the immune system mistakenly attacks the body itself. In the case of psoriasis, the immune system attacks the largest organ - the skin - causing inflammation and all the associated symptoms.” “Normally, skin diseases affect only the skin,” she adds. “But if you have psoriasis, the inflammation can occur in your internal organs as well, especially in the cardiovascular system. Psoriasis can even cause metabolic syndrome, which includes a range of associated diseases.” Diagnosis, misdiagnosis and delay in diagnosis Dr Bambroo explains that since psoriasis symptoms may resemble those of other diseases, especially other skin diseases, it may not be easy to diagnose until you visit a specialist. “Early diagnosis and appropriate treatment are essential if you have psoriasis,” she adds. “We often observe that if psoriasis patients are unable to diagnose or control their disease then they tend to develop obesity, diabetes and cardiovascular diseases in the long run.” “Another important aspect is psoriatic arthritis,” she adds. “Although it’s difficult to predict who will develop psoriatic arthritis eventually, care must be taken early on by all psoriasis patients to prevent it. Mostly, patients come to us after eight to nine years and they have symptoms like joint pain, inflammation and swelling in the small joints of the hands and deformities in finger joints. These are the long-term implications of psoriasis that need to be prevented.” Another long-term implication of psoriasis is related to mental health. “Patients usually get distressed, have depressive symptoms and may not feel accepted by society,” Dr Bambroo says, indicating that since people associate being social with being presentable - and psoriasis may threaten their presentability - patients often feel isolated and lonely. “These factors increase their risks of developing mental health issues in comparison to others around them,” she adds. “The biggest problem with psoriasis is the fact that it affects your confidence deeply.” Taking psoriasis seriously “Diagnosing psoriasis doesn’t take too much effort or investigation but people tend to take skin diseases more lightly than they should,” Dr Bambroo comments. “Most people may assume it’s just a small rash, it will go away by itself and won’t affect my health much. People are also unaware of their family medical history, and since genetics play a role in causing psoriasis, this may also lead to delayed diagnosis or misdiagnosis.” “But since predicting what health problems psoriasis may cause later is difficult, it’s important that you take this disease seriously. For example, if a young patient has psoriasis and we ignore it, it can have a lifelong and incapacitating impact,” she says. “This is the reason why early and correct treatment is vital in the case of psoriasis.” How to prevent flare-ups Dr Bambroo mentions that while you can’t control the genetic causes of psoriasis, you can manage the environmental factors that can trigger flare-ups. “Smoking and alcohol consumption tend to cause more flare-ups and so do obesity and lack of weight management. Taking care of these factors and looking after the health of your skin as winter season approaches can help psoriasis patients manage their flare-ups better. Stress also causes psoriasis flare-ups and we have especially seen many such cases during the COVID-19 pandemic. You have to keep yourself stress-free by meditating, doing yoga and following a daily routine,” she adds. Although psoriasis is not curable and is a chronic disease, there are many treatment options available now including corticosteroids, vitamin D derivative creams, immunosuppressants, etc. “It’s important, however, that doctors discuss viable options with the patients and customize their treatment to ensure they can actually adopt the necessary course,” Dr Bambroo says. “Going back to your doctor for follow-ups is also vital because not all medications are effective for psoriasis year after year. Plus, medications can also have side effects, so going back to your doctor for regular checkups is necessary.” “The biggest limitation in psoriasis treatment I’ve found is that the best treatments are also very expensive and not covered by insurance. I think it’s very important to include diseases like psoriasis in insurance plans and reimbursements,” she adds. “Psoriasis is not a cosmetic disease that’ll disappear like pimples do. This disease has a major impact on life and affects the dermatological life quality index (DLQI) of the patient.”
@Thanks for consolidated presentation
Cases that would interest you
- Login to View the image
Fever, dyspnea, and dry cough 7 days ago. Diagnosed with COVID-19 with positive nasal swab and IgM antibodies. Worsening dyspnea over the past 2 days. D-dimer 9.05. What are your suggestions on this?
Dr. Shekhar Verma4 Likes19 Answers - Login to View the image
61 yea old male underwent a recent CABG (on plavix) who came with sudden diffuse hemorrhagic rash and purpura as shown in pictures. Much more prominent in legs than the abdomen, very minimal on upper extremities and back. Otherwise everything else normal. No fever, no leukocytosis, not in any distress, GFR almost 50. Do you think plavix can cause that?
Dr. Gopal Arora3 Likes23 Answers - Login to View the image
77 yeas old female with a background notable of metastatic small bowel GIST. The patient is on chemotherapy, HTN, thyroidectomy, cholecystectomy presented with 10 day Hx of intermittent fevers, nonproductive cough, and increased Shortness of breath. PO2 8.8 on FiO2 0.85 on admission Admitted to ICU and Intubated Lung protective ventilation commenced but desaturated to 80% following RIJ CVC. Decompressed by the bedside and a CXR was performed that revealed large pneumothorax. The chest drain inserted with pneumothorax resolved gradually. 1 day after admission the admitting diagnosis was confirmed COVID-19. What are your experiences and knowledge of managing COVID-19 patients? Please discuss
Dr. Harshita Jain4 Likes21 Answers - Login to View the image
What is the diagnosis? A) Carpal tunnel syndrome B) Gout C) Hypoparathyroidism D) Rheumatoid arthritis E) Systemic sclerosis
Dr. Raj Sharma2 Likes27 Answers - Login to View the image
Hello everyone, Here are some important facts about COVID-19. From Clinical presentations to treatment. Please check it out and feel free to add more points. CLINICAL PRESENTATION: In a study describing 1099 patients with COVID-19 pneumonia in Wuhan, the most common clinical features at the onset of illness were: •Fever in 88% •Fatigue in 38% •Dry cough in 67% •Myalgias in 14.9% •Dyspnea in 18.7% Pneumonia appears to be the most common and severe manifestation of infection. In this group of patients breathing difficulty developed after a median of five days of illness. Acute respiratory distress syndrome developed in 3.4% of patients. Other symptoms •Headache •Sore throat •Rhinorrhea •Gastrointestinal symptoms About 80% of confirmed COVID-19 cases suffer from only mild to moderate disease and nearly 13% have the severe disease (dyspnea, respiratory frequency ≥30/minute, blood oxygen saturation≤93%, PaO2/FiO2 ratio <300, and/or lung infiltrates >50% of the lung field within 24-48 hours). Critical illness (respiratory failure septic shock, and/or multiple organ dysfunction/failure) is noted in only in less than 6% of cases. INCUBATION PERIOD: The exact incubation period is not known. It is presumed to be between 2 to 14 days after exposure, with most cases occurring within 5 days after exposure. THE SPECTRUM OF ILLNESS SEVERITY: Most infections are self-limiting. COVID-19 tends to cause more severe illness in the elderly population or in patients with underlying medical problems. As per the report from the Chinese center for disease control and prevention that included approximately 44,500 confirmed Infections with an estimation of disease severity. • Mild illness was reported in 81% of patients. • Severe illness (Hypoxemia, >50% lung involvement on imaging within 24 to 48 hours) in 14%. • Critical Disease (Respiratory failure, shock, multi-organ dysfunction syndrome) was reported in 5 percent. • Overall case fatality rate was between 2.3 to 5%. AGE AFFECTED: • Mostly middle-aged (>30 years) and elderly. • Symptomatic infection in children appears to be uncommon, and when it occurs, it is usually mild. **The 4th version of Belgian guidance for COVID 19 is published on19th March 2020. It is one of the most precise guidelines published yet. Some points from that: 1. Chloroquine is found to have good efficacy in vitro and it reduces the duration of viral shedding. But the drug has a narrow therapeutic window and cardiac toxicity is the most limiting side effect. 2. Hydroxychloroquine is more potent and is superior to chloroquine according to the very recent Gautret’ study. 3. Azithromycin may have a viral suppressive effect, but this needs to be proved as it was noticed accidentally in 6 patients of Gautret’ study. But I think it is a good choice for coverage of bacterial pneumonia. 4. Lopinavir/Ritonavir recently shown not to provide clinical benefit in hospitalized patients with COVID-19. It may reduce ICU stay if given within 10 days of infection but not beyond. 5. Remdesivir is promising but the studies are ongoing. Also, availability is a key issue. 6. Corticosteroids are not recommended as a systemic adjunctive treatment. 7. Paracetamol is the first-line analgesic and antipyretic over NSAIDs which are used with caution. 8. No need to stop ACEIs/ARBs in non-hospitalized patients. CONSIDER changing ACEIs/ARBs to another equivalent antihypertensive in hospitalized patients. 9. Antiviral therapy is not indicated in all patients with suspected/confirmed COVID19.
Dr. Prashant Vedwan123 Likes70 Answers
3 Likes